Literature DB >> 23467781

Neuroimaging evidence for the deficit subtype of schizophrenia.

Aristotle N Voineskos1, George Foussias, Jason Lerch, Daniel Felsky, Gary Remington, Tarek K Rajji, Nancy Lobaugh, Bruce G Pollock, Benoit H Mulsant.   

Abstract

IMPORTANCE: A major obstacle to the identification of the neurobiological correlates of schizophrenia is the substantial clinical heterogeneity present in this disorder. Dividing schizophrenia into "deficit" and "nondeficit" subtypes may reduce heterogeneity and facilitate identification of neurobiological markers of disease.
OBJECTIVE: To determine whether patients with deficit schizophrenia differ from patients with nondeficit schizophrenia and healthy controls in neuroimaging-based measures of white matter tracts and gray matter morphology.
DESIGN: A cross-sectional neuroimaging study of patients with the deficit or nondeficit subtype of schizophrenia and healthy controls.
SETTING: University hospital. PARTICIPANTS: Seventy-seven patients with schizophrenia and 79 healthy controls.
INTERVENTIONS: All participants were administered the Structured Clinical Interview for DSM-IV-TR Axis I Disorders and the Positive and Negative Syndrome Scale; IQ was measured using the Wechsler Test for Adult Reading; global cognitive impairment was grossly assessed using the Mini-Mental State Examination; comorbid physical illness burden was measured by administration of the Clinical Information Rating Scale-Geriatrics; high-resolution magnetic resonance imaging was performed as part of a multimodal imaging protocol; and deficit status was determined using the proxy scale for the deficit syndrome. MAIN OUTCOME MEASURES: Diffusion-based measures of white matter tracts, cortical thickness, cortical surface area, and volumes of subcortical structures.
RESULTS: In both an individually matched approach (18 patients with deficit schizophrenia, 18 patients with nondeficit schizophrenia, and 18 healthy controls) and an unmatched population-based approach (18 patients with deficit schizophrenia, 59 patients with nondeficit schizophrenia, and 79 health controls), the patients with deficit schizophrenia demonstrated disruption of white matter tracts compared with patients with nondeficit schizophrenia and healthy controls at the right inferior longitudinal fasciculus, the right arcuate fasciculus, and the left uncinate fasciculus. These findings were supported in patients with first-episode schizophrenia (n = 20) who had a deficit score that was strongly correlated with disruption at these same tracts. In contrast, patients with schizophrenia of either subtype exhibited cortical thickness reductions compared with healthy controls, in near-identical neuroanatomic patterns. Surface areas and subcortical volumes did not differ significantly among the 3 groups. CONCLUSIONS AND RELEVANCE: The convergence of findings in our individually matched sample, our unmatched overall sample, and our first-episode schizophrenia sample demonstrate (1) white matter tract disruption as a neurobiological feature of the deficit syndrome and (2) reductions in cortical thickness as a common feature of patients with a diagnosis of schizophrenia. When taken with previous results in gray matter, our findings in white matter tracts point to neural circuitry important for socioemotional function as a core neurobiological feature of the deficit subtype of schizophrenia.

Entities:  

Mesh:

Year:  2013        PMID: 23467781     DOI: 10.1001/jamapsychiatry.2013.786

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  69 in total

1.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

Review 2.  Glutamate-mediated excitotoxicity in schizophrenia: a review.

Authors:  Eric Plitman; Shinichiro Nakajima; Camilo de la Fuente-Sandoval; Philip Gerretsen; M Mallar Chakravarty; Jane Kobylianskii; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

3.  Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia.

Authors:  Wei Lei; Wei Deng; Mingli Li; Zongling He; Yuanyuan Han; Chaohua Huang; Xiaohong Ma; Qiang Wang; Wanjun Guo; Yinfei Li; Lijun Jiang; Qiyong Gong; Xun Hu; Nanyin Zhang; Tao Li
Journal:  Psychiatry Res       Date:  2015-09-11       Impact factor: 3.222

Review 4.  A review of recent literature employing electroencephalographic techniques to study the pathophysiology, phenomenology, and treatment response of schizophrenia.

Authors:  Gary Marcel Hasey; Michael Kiang
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

5.  Methadone use in a male with the FMRI premutation and FXTAS.

Authors:  Zukhrofi Muzar; Reymundo Lozano; Andrea Schneider; Patrick E Adams; Sultana M H Faradz; Flora Tassone; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2015-04-21       Impact factor: 2.802

6.  Actigraphy studies and clinical and biobehavioural correlates in schizophrenia: a systematic review.

Authors:  Zi Ying Wee; Samantha Wei Lee Yong; Qian Hui Chew; Cuntai Guan; Tih Shih Lee; Kang Sim
Journal:  J Neural Transm (Vienna)       Date:  2019-03-19       Impact factor: 3.575

7.  The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia.

Authors:  Ofer Pasternak; Carl-Fredrik Westin; Brian Dahlben; Sylvain Bouix; Marek Kubicki
Journal:  Schizophr Res       Date:  2014-08-10       Impact factor: 4.939

Review 8.  Prefrontal cortex and the dysconnectivity hypothesis of schizophrenia.

Authors:  Yuan Zhou; Lingzhong Fan; Chenxiang Qiu; Tianzi Jiang
Journal:  Neurosci Bull       Date:  2015-03-11       Impact factor: 5.203

9.  Investigation of superior longitudinal fasciculus fiber complexity in recent onset psychosis.

Authors:  Philip R Szeszko; Ek Tsoon Tan; Aziz M Uluğ; Peter B Kingsley; Juan A Gallego; Kathryn Rhindress; Anil K Malhotra; Delbert G Robinson; Luca Marinelli
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-10-28       Impact factor: 5.067

10.  Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.

Authors:  Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.